Health insurer Cigna will stop covering GLP-1 weight-loss drugs including Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound in its employee health plan effective July 1, according to materials viewed by Reuters on Tuesday.[#item_full_content]
EXCLUSIVE: Russian document reveals sweeping Iran plan spanning nuclear, finance and aviation
Settembre 21, 2026
EXCLUSIVE: A nonpublic Russian government document obtained and reviewed by Fox News Digital reveals how Moscow sought to deepen its relationship with Iran far beyond
